Capital Structure Of Pharmaceutical And Performance An Empirical Study

Pharmaceutical industry has become the world wide attention and to develop, compete fiercely with each other as a focus. In China, the pharmaceutical industry has increasingly become a focus of attention of the whole society. The capital structure of the pharmaceutical industry and the relationship between corporate performance can not only affect the pharmaceutical industry knowledge and understanding of the development of the internal factors, but also through the adjustment of capital structure of pharmaceutical companies to promote healthy development toward maturity.Therefore, China's pharmaceutical industry, this paper Capital Structure and Corporate Performance study has important practical significance.In the paper the structure of the arrangement, the first chapter is outlines the background papers and practical significance, explained domestic and foreign scholars to date on the Capital Structure and Corporate Performance of theoretical perspectives and research methods and results, and introduced the idea of thesis research, using research methods and The innovation of this paper and weaknesses. The second chapter on China's overall capital structure of listed companies with the theoretical analysis of corporate performance. Chapter III of the listed companies in the pharmaceutical industry in China's capital structure and corporate performance status were analyzed. The fourth chapter is a key part of - Analysis. Then, multiple linear regression model was constructed, and through statistical analysis by describing the sample shows capital structure and corporate performance status. Finally, the previous paper based on the analysis, linear regression model of regression analysis and empirical results were summarized and analyzed.Chapter V of policy recommendations, from the optimization of capital structure and good external conditions for the construction of two relevant recommendations and measures.